Author:
Guo Xuxue,Huang Mei,Zhang Haonan,Chen Qianhui,Hu Ying,Meng Yan,Wu Changjie,Tu Chenge,Liu Yongfeng,Li Aimin,Li Qingyuan,Zhou Peirong,Liu Side
Abstract
Abstract
Background
The critical role of thioredoxin-interacting protein (TXNIP) in cellular sulfhydryl redox homeostasis and inflammasome activation is already widely known, however, no pan-cancer analysis is currently available.
Methods
We thus first explored the potential roles of TXNIP across thirty-three tumors mainly based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.
Results
TXNIP is lowly expressed in most cancers, and distinct associations exist between TXNIP expression and the prognosis of tumor patients. TXNIP expression was associated with tumor mutational burden, microsatellite instability, mismatch repair genes, tumor infiltrating immune cell abundance as well as cancer-associated fibroblasts. Moreover, ubiquitin mediated proteolysis, protein post-translational modification and other related pathways were involved in the functional mechanisms of TXNIP.
Conclusions
Our first pan-cancer study comprehensively revealed the carcinostatic role of TXNIP across different tumors. And this molecule may be considered as a potential immunological and prognostic biomarker.
Funder
Guangdong Medical Science and Technology Research Fund Project
Foundation of Nanfang Hospital, Southern Medical University
National Natural Science Foundation of China
Basic and Applied Basic Research Foundation of Guangdong Province
Guangzhou Basic and Applied Basic Research Fund
National Key Research and Development Program of China
the Guangdong Science and Technology Plan Project
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献